According to the Tumor Immune Dysfunction and Exclusion (TIDE) [10] tool, the results exhibited that the Exclusion score, CAF score, PD-1, CTLA4, IDO1, and TIGIT score of the high-risk group were higher than those of the low-risk group (Fig. 10B). This evidence concerns the gene CTLA4 and neoplasm.